Current Report Filing (8-k)
January 27 2020 - 6:03AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report
(Date of earliest event reported): January 6, 2020
ETHEMA HEALTH
CORPORATION
f/k/a GREENESTONE
HEALTHCARE CORPORATION
(Exact name
of registrant as specified in its charter)
Colorado
|
000-15078
|
84-1227328
|
(State
or other jurisdiction of
incorporation
or organization)
|
(Commission
File Number)
|
(IRS
Employer
Identification
No.)
|
810
Andrews Avenue
Delray
Beach, Florida 33483
|
(Address
of principal executive offices)
|
(416)
500-0020
|
(Registrant’s
telephone number, including area code)
|
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
[
]
|
|
Written
communications pursuant to Rule 425 under the Securities Act
|
[
]
|
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act
|
[
]
|
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
[
]
|
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item
5.03 Amendments to Articles of Incorporation or Bylaws: Increase to authorized shares.
On January
6, 2020, a majority of the holders of the issued and outstanding shares of common stock of Ethema Health Corporation (the “Company”)
approved the increase of its authorized aggregate number of shares of common stock issuable from nine hundred million (900,000,000)
to ten billion (10,000,000,000), as a result the Company’s current authorized capital is now ten billion thirteen million
(10,013,000,000) shares of capital stock, consisting of (i) ten billion (10,000,000,000) shares of common stock, par value $0.0001
per share (the “Common Stock”); (ii) three million (3,000,000) Series A Convertible Preferred Stock, par value $1.00
per share (the “Convertible Preferred Stock”); and (iii) ten million (10,000,000) shares of Series B Preferred Stock,
par value $0.0001 per share (“Series B Convertible Preferred Stock”). On the same day, the Board of Directors of the
Company adopted the resolution to amend its Articles of Incorporation to effect the increase to the authorized aggregate number
of shares of common stock.
The Company filed
a Certificate of Amendment (the “Amendment”) to Articles of Incorporation with Colorado’s Secretary of State
on January 14, 2020 for the Increase of Authorized Stock. On January 8, 2016, the Company received a filed and stamped copy from
Colorado’s Secretary of State on January 14, 2020.
Item 9.01
Financial Statements and Exhibits
(d) Exhibits.
The following exhibit is furnished with this report:
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.
|
ETHEMA
HEALTH CORPORATION
|
|
|
|
Date: January 24,
2020
|
By:
|
/s/
Shawn E. Leon
|
|
|
Shawn E. Leon
|
|
|
Chief Executive
Officer
|
Ethema Health (PK) (USOTC:GRST)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ethema Health (PK) (USOTC:GRST)
Historical Stock Chart
From Apr 2023 to Apr 2024